New analysis adds heart failure data for sitagliptin
Monday, August 31, 2015 - 09:10
in Health & Medicine
Patients with type-2 diabetes and cardiovascular disease can safely take the antihyperglycemic drug sitagliptin without an increased risk of cardiovascular complications - even if they have a history of heart failure - a new analysis shows.